QA: Sonnet BioTherapeutics Holdings Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001106838_2023_Sonnet_BioTherapeutics_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001106838, Sonnet BioTherapeutics Holdings Inc.

  xvar xval
0 AssetsCurrent 5,413,927
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 46,211
3 remainder_Assets 369,874
4 LiabilitiesCurrent 8,164,819
5 LiabilitiesNoncurrent 203,912
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,575,283
9 ResearchAndDevelopmentExpense 21,444,019
10 remainder_Expenses 0
11 remainder_Revenues 349,943
12 remainder_NetIncome -52,482
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,830,012
1 Liabilities 8,368,731
2 Expenses 30,019,302
3 Revenues 349,943
4 StockholdersEquity -2,538,719
5 NetIncome -29,721,841
6 ComprehensiveNetIncome -29,721,841
7 BaseVar 22,310,235
8 EconomicCapitalRatio -4.80

Edgar->Model Mapping

Feature Distribution

Change over Time